IL6 and neoplasm: found that IL‐6 secreted by MSCs can increase the secretion of endothelin‐1 (ET‐1) in human colorectal cancer cells, which induces the activation of Akt and ERK in endothelial cells, thereby enhancing their capacity for recruitment and angiogenesis to the tumor.